Literature DB >> 11949732

Selecting the target and the message for a stroke public education campaign: a local survey conducted by neurologists.

J Montaner1, C Vidal, C Molina, J Alvarez-Sabin.   

Abstract

In order to determine the baseline knowledge of stroke among population (terminology, signs and symptoms, risk factors (RF) and attitude) to select the best target and message, prior to educational campaigns, a structured interview using close-ended questions was conducted by neurologists among 1000 users of several Primary Health Centers around our Hospital, randomly sampled. In our population 10.1% totally ignores the disease; of the remainder, 50% has a good knowledge of signs and symptoms and 37% of RF. To be a woman, (OR: 1.7; 95% CI: 1.2-2.5), the university education (OR: 6.6; 95% CI: 3.0-14.7), the age between 45 and 65 years (OR: 2.5; 95% CI: 1.3-5.0) and to have an afflicted relative (OR: 1.4; 95% CI: 1.001-2.0) are associated with a better stroke knowledge. If symptoms are transient, there is a trend to contact primary physicians (43.5%). Less than a quarter of our population have a good knowledge of the disease. Stroke is considered an emergency unlike TIA. The benefits of public education and the best message for each target population are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11949732     DOI: 10.1023/a:1014581003849

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

Authors:  I L Katzan; A J Furlan; L E Lloyd; J I Frank; D L Harper; J A Hinchey; J P Hammel; A Qu; C A Sila
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

3.  Patients' awareness of stroke signs, symptoms, and risk factors.

Authors:  R Kothari; L Sauerbeck; E Jauch; J Broderick; T Brott; J Khoury; T Liu
Journal:  Stroke       Date:  1997-10       Impact factor: 7.914

4.  Public perception of stroke warning signs and knowledge of potential risk factors.

Authors:  A M Pancioli; J Broderick; R Kothari; T Brott; A Tuchfarber; R Miller; J Khoury; E Jauch
Journal:  JAMA       Date:  1998 Apr 22-29       Impact factor: 56.272

5.  Stroke patients' knowledge of stroke. Influence on time to presentation.

Authors:  L S Williams; A Bruno; D Rouch; D J Marriott
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Effects of public and professional education on reducing the delay in presentation and referral of stroke patients.

Authors:  M J Alberts; A Perry; D V Dawson; C Bertels
Journal:  Stroke       Date:  1992-03       Impact factor: 7.914

8.  [Stroke: a stranger among the people].

Authors:  J Montaner; A Mauleón; C Vidal; C Molina; J Alvarez-Sabín
Journal:  Rev Neurol       Date:  1998-12       Impact factor: 0.870

9.  Patients' attitudes towards TIA.

Authors:  J E Shelton; K J Gaines
Journal:  Va Med Q       Date:  1995

10.  Community education for cardiovascular health.

Authors:  J W Farquhar; N Maccoby; P D Wood; J K Alexander; H Breitrose; B W Brown; W L Haskell; A L McAlister; A J Meyer; J D Nash; M P Stern
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

View more
  9 in total

Review 1.  Stroke knowledge in Spanish-speaking populations.

Authors:  Maximiliano A Hawkes; Sebastián F Ameriso; Joshua Z Willey
Journal:  Neuroepidemiology       Date:  2015-04-09       Impact factor: 3.282

2.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

3.  Low awareness of transient ischemic attacks and risk factors of stroke in a Swiss urban community.

Authors:  Krassen Nedeltchev; Urs Fischer; Marcel Arnold; Liliane Kappeler; Heinrich P Mattle
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

4.  Gender-specific differences in stroke knowledge, stroke risk perception and the effects of an educational multimedia campaign.

Authors:  Juergen J Marx; Bianca Klawitter; Andreas Faldum; Bernhard M Eicke; Birgit Haertle; Marianne Dieterich; Max Nedelmann
Journal:  J Neurol       Date:  2009-09-22       Impact factor: 4.849

5.  An educational multimedia campaign has differential effects on public stroke knowledge and care-seeking behavior.

Authors:  Juergen J Marx; Max Nedelmann; Birgit Haertle; Marianne Dieterich; Bernd M Eicke
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

6.  Stroke awareness in the general population: knowledge of stroke risk factors and warning signs in older adults.

Authors:  Anne Hickey; Ann O'Hanlon; Hannah McGee; Claire Donnellan; Emer Shelley; Frances Horgan; Desmond O'Neill
Journal:  BMC Geriatr       Date:  2009-08-05       Impact factor: 3.921

7.  Risk awareness in secondary stroke prevention: a review of the literature.

Authors:  Julia Slark; Pankaj Sharma
Journal:  JRSM Cardiovasc Dis       Date:  2014-02-04

8.  Barriers from calling ambulance after recognizing stroke differed in adults younger or older than 75 years old in China.

Authors:  Shengde Li; Li-Ying Cui; Craig Anderson; Chunpeng Gao; Chengdong Yu; Guangliang Shan; Longde Wang; Bin Peng
Journal:  BMC Neurol       Date:  2019-11-12       Impact factor: 2.474

9.  Does socioeconomic position affect knowledge of the risk factors and warning signs of stroke in the WHO European region? A systematic literature review.

Authors:  Katie Stack; Wendy Robertson; Clare Blackburn
Journal:  BMC Public Health       Date:  2020-09-29       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.